SHENCHUNWANG PREPARATION DIN 02230802
Status: Cancelled (Unreturned Annual)
Holder: SUCAN INTERNATIONAL TRADING COMPANY
Molecule: CINNAMOMUM ZEYLANICUM
Health Canada record
| Active ingredient(s) | CINNAMOMUM ZEYLANICUM 400 MG; DIOSCOREA OPPOSITA 3000 MG |
|---|---|
| Dosage form | Liquid |
| Route | Oral |
| Schedule | |
| Class | Human |
| ATC | |
| Original market date | |
| Current status date | 18-Jul-2017 |
| Source | Health Canada DPD |
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing CINNAMOMUM ZEYLANICUM
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02058103 | CINNAMOMUM-INJEEL FORTE LIQ (6D,12D,30D,200D/1.1ML) | BIOLOGISCHE HEILMITTEL HEEL GMBH | Liquid | CINNAMOMUM ZEYLANICUM 6 D | Cancelled Post Market |
| 02058081 | CINNAMOMUM-INJEEL LIQ (12D,30D,200D/1.1ML) | BIOLOGISCHE HEILMITTEL HEEL GMBH | Liquid | CINNAMOMUM ZEYLANICUM 12 D | Cancelled Post Market |
| 02077507 | HOMEOPATHIC MEDICINE (S NO. 576) DPS 30C | TOTAL HEALTH CENTRE | Drops | CINNAMOMUM ZEYLANICUM 30 C | Cancelled Post Market |
| 02174197 | SPIRITUS CONTRA TUSSIM - DROPS | WELEDA AG HEILMITTELBETRIEBE | Liquid; Drops | CINNAMOMUM ZEYLANICUM 2 D; PRUNUS LAUROCERASUS L. 3 D; NUX MOSCHATA 3 D; ANGELICA 3 D; MELISSA OFFICINALIS 3 D | Cancelled Post Market |